Thursday, November 28, 2019

WuXi ATU and GeneMedicine Sign Development and Manufacturing Agreement for Oncolytic Virus Products

SHANGHAI and SEOUL, South Korea, Nov. 28, 2019 /PRNewswire/ -- WuXi ATU Co., Ltd., (WuXi ATU) - a subsidiary of WuXi AppTec, and GeneMedicine - a South Korea-based gene therapy biotechnology company, have formed a strategic partnership for the development and manufacturing of oncolytic...



from PR Newswire: https://ift.tt/2Otw6EG

No comments:

Post a Comment